Oncologist 26 , e608e621 (2021)
Multiple randomised, placebo-controlled trials have tested GLP-1 drugs as add-on therapy to insulin in people with T1D, and the picture that emerges is consistent, if modest: meaningful weight loss, real reductions in daily insulin needs, and improvements in CGM time in range
Support for cardiovascular health : B12 helps improve markers of heart health, potentially reducing the risk of heart-related complications in people with type 2 diabetes
The second inconvenient truth: individual response variability is real, but it doesn't invalidate the circadian data
This will stop your skin from becoming TOO dark, or from forming those dark spots that are so visible on your skin when you spend too much time in the sun
Department of Health and Human Services, Robert F